Products & Reviews

The iLite® Functional Bioassay portfolio consists of cell lines provided in an “assay-ready” format for a rapid and convenient workflow. The assay-ready format also reduces assay variability, optimizing its use in screening, characterization, stability, and potency studies. iLite cell lines can be tailored to virtually any biopharmaceutical target.

The iLite® Fc Effector Reporter Gene Bioassays Portfolio offers a variety of reporter gene cell lines and target cells that can be used in MOA-reflective assays to measure the Fc effect of antibodies and other biologics that specifically bind and activate Fc receptors. Using a Luciferase reporter gene system offers a convenient and powerful way of measuring antibodies' in vitro efficacy in triggering ADCC and ADCP.

In diagnosis of Rheumatoid Arthritis (RA), the measurement of anti-CCP is integral. People who test positive for Anti-CCP, are very likely to develop or have already developed RA, but not all who have RA, necessarily develop anti-CCP. Early detection of RA is crucial for reducing tissue damage.

Calpro, a Svar subsidiary, produced the first ever commercial kits available for measuring Calprotectin setting industry standards. It offers a broad range of assays, including ELISA, PETIA (Turbidimetric assay), and rapid Point-of-Care (PoC) and self-tests for IBD monitoring. Calpro also provides RUO ELISAs for various bodily fluids and a rapid CalproSmart test as an RUO product.

A biologically relevant and powerful way to assess CD32/FcyRlla induced effects.

A biologically relevant and powerful way to assess CD32/FcyRlla induced effects.

Engineered, homologous, and specific target cells that enable screening for antibody-induced effector functions.

The iLite® CD3 Effector Cell line is a reporter gene cell line that offers a convenient and powerful way of measuring the efficacy antibodies have to elicit  T cell activation through CD3  interactions.

Svar CRO Services provides direct value through an extensive toolbox of in-house products, scientific expertise, and end-to-end customizable solutions – everything to ensure the success of your drug development program.​

Expert Biomarker Discovery Services using cutting-edge technologies such as high-quality proteomics with Proximity Extension Assay (PEA) technology from Olink, and ultra-sensitive detection with proven Simoa technology. We offer ideal broad screening-to-targeted biomarker discovery solutions in different therapeutic areas.